LFCR Lifecore Biomedical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LFCR

Price (delayed)

$6.155

Market cap

$188.02M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.32

Enterprise value

$281.55M

Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for ...

Highlights
The company's quick ratio rose by 30% QoQ
Lifecore Biomedical's debt has decreased by 25% YoY and by 11% from the previous quarter
The company's gross margin rose by 32% QoQ but it fell by 23% YoY
Lifecore Biomedical's gross profit has decreased by 28% YoY but it has increased by 4.5% QoQ
LFCR's equity has dropped by 112% since the previous quarter and by 105% year-on-year
LFCR's revenue is down by 21% QoQ and by 7% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.landec.com
Peers: OPTN OPK ORGO

Key stats

What are the main financial stats of LFCR
Market
Shares outstanding
30.55M
Market cap
$188.02M
Enterprise value
$281.55M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.73
Earnings
Revenue
$103.27M
EBIT
-$81.61M
EBITDA
-$68.32M
Free cash flow
-$38.92M
Per share
EPS
-$3.32
Free cash flow per share
-$1.3
Book value per share
-$0.14
Revenue per share
$3.45
TBVPS
$7.86
Balance sheet
Total assets
$253.55M
Total liabilities
$218.46M
Debt
$112.62M
Equity
-$4.23M
Working capital
$54.59M
Liquidity
Debt to equity
-26.63
Current ratio
2.39
Quick ratio
1.22
Net debt/EBITDA
-1.37
Margins
EBITDA margin
-66.2%
Gross margin
27.1%
Net margin
-96.4%
Operating margin
-21.1%
Efficiency
Return on assets
-38.4%
Return on equity
-215.8%
Return on invested capital
-31.8%
Return on capital employed
-38.1%
Return on sales
-79%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

LFCR stock price

How has the Lifecore Biomedical stock price performed over time
Intraday
-2.76%
1 week
-2.61%
1 month
13.98%
1 year
40.53%
YTD
-0.57%
QTD
15.91%

Financial performance

How have Lifecore Biomedical's revenue and profit performed over time
Revenue
$103.27M
Gross profit
$27.99M
Operating income
-$21.8M
Net income
-$99.56M
Gross margin
27.1%
Net margin
-96.4%
LFCR's operating margin has plunged by 99% YoY
The company's operating income has shrunk by 85% YoY but it rose by 21% QoQ
The company's gross margin rose by 32% QoQ but it fell by 23% YoY
Lifecore Biomedical's gross profit has decreased by 28% YoY but it has increased by 4.5% QoQ

Growth

What is Lifecore Biomedical's growth rate over time

Valuation

What is Lifecore Biomedical stock price valuation
P/E
N/A
P/B
N/A
P/S
1.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.73
LFCR's EPS is up by 18% QoQ and by 16% YoY
LFCR's equity has dropped by 112% since the previous quarter and by 105% year-on-year
LFCR's revenue is down by 21% QoQ and by 7% YoY
The price to sales (P/S) is 16% lower than the 5-year quarterly average of 2.2 and 3.2% lower than the last 4 quarters average of 1.9

Efficiency

How efficient is Lifecore Biomedical business performance
Lifecore Biomedical's ROE has plunged by 169% YoY and by 25% from the previous quarter
Lifecore Biomedical's return on invested capital has increased by 26% QoQ
The ROA has contracted by 21% YoY but it has grown by 15% from the previous quarter
LFCR's ROS is up by 17% YoY

Dividends

What is LFCR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LFCR.

Financial health

How did Lifecore Biomedical financials performed over time
LFCR's total assets is 16% more than its total liabilities
LFCR's total liabilities is up by 34% from the previous quarter and by 17% YoY
The company's quick ratio rose by 30% QoQ
LFCR's equity has dropped by 112% since the previous quarter and by 105% year-on-year
Lifecore Biomedical's debt has decreased by 25% YoY and by 11% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.